Leveraging Interpretable AI for Deciphering Signature Histopathologic Patterns.
J Cutan Pathol 2026 Apr; 53(4):370-376.

Abstract

BACKGROUND

Leukocytoclastic vasculitis (LCV) and microvascular occlusion (MVO) are distinct histopathologic patterns underlying dermatologic diagnoses of purpura. This study explores the potential of attention-based artificial intelligence (AI) models to enhance diagnostic accuracy and provide interpretable insights in differentiating these conditions, serving as a proof of concept for the application of explainable AI in dermatopathology.

METHODS

We compared the performance of two attention-based AI models, clustering-constrained-attention multiple-instance learning (CLAM) and attention multiple instance learning (MIL), in analyzing whole slide images of LCV and MVO cases. The models were trained and evaluated using a cohort of 69 biopsies. Performance metrics included precision, recall, accuracy, AUROC, and F1 score. Attention-based heatmaps were generated to highlight diagnostic regions and reveal histopathologic patterns.

RESULTS

The CLAM model outperformed the attention MIL model across all evaluation metrics. Generated heatmaps effectively highlighted key diagnostic regions, including subtle areas of occlusion in the superficial papillary dermis of MVO cases.

CONCLUSIONS

This study demonstrates the potential of attention-based AI models to improve diagnostic accuracy and provide interpretable insights in differentiating LCV and MVO. The use of explainable AI and heatmaps offers a valuable tool for pathologists, enhancing their ability to identify and understand subtle histopathologic patterns.

Authors+Show Affiliations

Gehlhausen JR0000-0002-7659-1105Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Luyten STColumbia School of Medicine, New York, New York, USA.
Deng JDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA.
Micevic GDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Cohen JM0000-0002-7709-0548Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Damsky WDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Cowper SEDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
McNiff JMDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Ko CJ0000-0003-2270-2524Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA. Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

41479397